Phase II Study of Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide plus /- Trastuzumab Followed by Docetaxel in Locally Advanced Breast Cancer (LABC)

被引：0
|
作者：
Tuxen, M. K. [1 ]
Cold, S. [2 ]
Tange, U. B. [3 ]
Soendergaard, S. B. [4 ]
Nielsen, D. L. [1 ]
机构：
[1] Herlev Univ Hosp, Dept Oncol, DK-2730 Herlev, Denmark
[2] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark
[3] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark
[4] Herlev Univ Hosp, Dept Nucl Med, DK-2730 Herlev, Denmark
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [31] Phase II study of neoadjuvant treatment with docetaxel, doxorubicin and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Khosravi-Shahi, P.
    Mendez, M.
    Quiben, R.
    Palomero, I.
    Izarzugaza, Y.
    Belon, J.
    Garcia-Alfonso, P.
    Perez-Manga, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Gumersindo Pérez Manga
    Parham Khosravi Shahi
    Miguel Méndez Ureña
    Rosa Quiben Pereira
    María Isabel Palomero Plaza
    Yann Izarzugaza Peron
    Ricardo González Del Val
    Joaquín Belón Carrión
    Esperanza Pérez Cañón
    Pilar García Alfonso
    [J]. Breast Cancer, 2010, 17 : 205 - 211
  • [33] Clinical Advantages of Neoadjuvant Docetaxel (T) and Carboplatin (C) ± Trastuzumab (H) in Locally Advanced Breast Cancer (LABC)
    Chang, H. R.
    Glaspy, J.
    Gornbein, J.
    Kass, F. C.
    Allison, M. A.
    Chung, D. U.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 571S - 571S
  • [34] Docetaxel (T) plus capecitabine (X) with or without trastuzumab (H) neoadjuvant therapy for locally advanced breast cancer (BC): Phase II study
    Lybaert, W.
    Wildiers, H.
    Neven, P.
    Amant, F.
    Christiaens, M.
    Van Limbergen, E.
    Weltens, C.
    Drijkoningen, R.
    Debrock, G.
    Paridaens, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer:: A randomized phase II trial
    Schneeweiss, Andreas
    Lauschner, Ilka
    Ruiz, Amparo
    Guerrero, Angel
    Sanchez-Rovira, Pedro
    Segui, Miguel Angel
    Goerke, Kay
    Wolf, Michael
    Manikhas, Alexey G.
    Wacker, Juergen
    Marme, Frederik
    Lichter, Peter
    Sinn, Hans-Peter
    Sohn, Christof
    Mansouri, Kambiz
    Bauknecht, Thomas
    Hahn, Meinhard
    [J]. CLINICAL BREAST CANCER, 2007, 7 (07) : 555 - 558
  • [36] Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx®) and paclitaxel in locally advanced breast cancer:: a phase II study by the Hellenic Cooperative Oncology Group
    Gogas, H
    Papadimitriou, C
    Kalofonos, HP
    Bafaloukos, D
    Fountzilas, G
    Tsavdaridis, D
    Anagnostopoulos, A
    Onyenadum, A
    Papakostas, P
    Economopoulos, T
    Christodoulou, C
    Kosmidis, P
    Markopoulos, C
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (11) : 1737 - 1742
  • [37] Phase II study of neoadjuvant docetaxel/vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer
    Limentani, Steven A.
    Brufsky, Adam M.
    Erban, John K.
    Jahanzeb, Mohammed
    Lewis, Deborah
    [J]. CLINICAL BREAST CANCER, 2006, 6 (06) : 511 - 517
  • [38] Multicenter phase II study of neoadjuvant capecitabine (X), docetaxel (T) ± trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): final analysis.
    Wildiers, H.
    Neven, P.
    Christiaens, M-R
    Fesneaux, G.
    Amant, F.
    Weltens, C.
    Smeets, A.
    van Limbergen, E.
    Debrock, G.
    Renard, V
    Paridaens, R.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 335S - 335S
  • [39] Neoadjuvant administration of gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in large or locally advanced operable breast cancer: a phase II study.
    Chacko, RT
    Julka, PK
    Parshad, R
    Nair, A
    Nag, S
    Dhindsa, N
    Koppiker, CB
    Nair, S
    Abhyankar, JR
    Dawar, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S109 - S110
  • [40] A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer
    Yoo, Changhoon
    Kim, Sung-Bae
    Ahn, Jin-Hee
    Kim, Jeong Eun
    Jung, Kyung Hae
    Gong, Gyung-Yub
    Son, Byung-Ho
    Ahn, Sei-Hyun
    Ahn, Seung Do
    Kim, Hak-Hee
    Shin, Hee Jung
    Kim, Woo Kun
    [J]. CANCER RESEARCH AND TREATMENT, 2015, 47 (03): : 406 - 415
12345